Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
American Journal of Case Reports | Hepatic AL Amyloidosis without Significant Light Chain Elevation in a Patient Treated with CyBorD Plus Daratumumab - Article abstract #933241
kappa versus lambda light chains in paraproteinemias - Renal Fellow Network
When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book
Manni Mohyuddin on X: "130!!!! So thats how high the kappa light goes! And hence,an adjusted kappa/lambda ratio from "0.26 to 1.65" to "0.37 to 3.1" has been suggested to better pick
Chronic diarrhea - The poetic masquerade
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Kappa and Lambda Light Chains - HealthTree for Multiple Myeloma
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid - Franz F Konen, Philipp Schwenkenbecher, Ulrich Wurster, Konstantin F Jendretzky, Nora Möhn, Stefan Gingele, Kurt-Wolfram Sühs, Malte
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study - eBioMedicine
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
(PDF) Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect